ANIP

ANIP Operating Expenses

$488.03MTTM · USD

Period ending:

ANIP FY Operating ExpensesUSD
ANIP FY Operating Expenses1998-12-31: $2.78M1999-12-31: $1.60M2000-12-31: $3.69M2001-12-31: $4.53M2002-12-31: $6.64M2003-12-31: $6.11M2004-12-31: $12.34M2005-12-31: $9.56M2006-12-31: $11.00M2007-12-31: $9.17M2008-12-31: $21.79M2009-12-31: $39.68M2010-12-31: $45.81M2011-12-31: $51.31M2012-12-31: $25.47M2013-12-31: $19.21M2014-12-31: $24.49M2015-12-31: $30.93M2016-12-31: $53.08M2017-12-31: $68.58M2018-12-31: $93.19M2019-12-31: $127.04M2020-12-31: $137.33M2021-12-31: $155.32M2022-12-31: $212.88M2023-12-31: $258.33M2024-12-31: $363.58M2025-12-31: $369.41M$369.41M$0.00
1998-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ANIP operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.

Ani Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
369,409,000
363,582,000
258,332,000
212,883,000
155,319,000
137,334,000
127,042,000
93,193,000
68,578,000
53,078,000
30,930,000
24,491,000
19,210,000
25,472,318
51,311,990
45,813,848
39,683,608
21,794,471
9,172,498
10,998,859
9,560,573
12,344,517
6,111,437
6,644,541
4,533,163
3,689,203
1,604,942
2,782,476

Compare operating expenses

All ANIP financial metrics · ANIP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.